Will adjuvant chemotherapy improve outcome after preoperative chemoradiation?

Multidisciplinary Management of Rectal Cancer: Questions and Answers

Volumn , Issue , 2011, Pages 217-225

  Glimelius, Bengt ^a,b   Nygren, Peter ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927685915     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-25005-7_22     Document Type: Chapter

References (53)

1. Aamodt R, Jonsdottir K, Andersen SN et al (2009) Differences in protein expression and gene ampli fication of cyclins between colon and rectal ade-nocarcinomas. Gastroenterol Res Pract 2009:285830
2. Alberts SR, Sargent DJ, Smyrk TC et al (2010) Adjuvant mFOLFOX6 with or without cetuximab in KRAS wild-type patients with resected stage III colon cancer: results from NCCTG intergroup phase III trial N0147. J Clin Oncol 28:A3507
3. Allegra CJ, Yothers G, O'Connell MJ et al (2011) Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 29:11-16
4. Andre T, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leu-covorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27: 3109-3116
5. Biagi JJ, Raphael M, King WD et al (2011) The impact of time to adjuvant chemotherapy on survival in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 29(suppl 4):A364
6. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123
7. Bujko K, Glynne-Jones R, Bujko M (2010) Does adjuvant fluoropyrimidine-based chemotherapy provide a bene fit for patients with resected rectal cancer who have already received neoadjuvant radio(chemo) therapy? A Systematic Review of Randomized Trials. Ann Oncol 21:1743-1750
8. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomised trial comparing preoperative short-course radiotherapy vs preoperative conventionally fractionated chemoradia-tion for rectal cancer. Br J Surg 93:1215-1223
9. Cafiero F, Gipponi M, Peressini A et al (2000) Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol 75:80-88
10. Chua YJ, Barbachano Y, Cunningham D et al (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-de fined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241-248
11. Cionini L, Manfredi B, Sainato A et al (2001) Randomized study of postoperative chemotherapy after preoperative chemoradiation in locally advanced rectal cancer. Preliminary results. Eur J Cancer 37: S300 (Abstr)
12. Collette L, Bosset JF, den Dulk M et al (2007) Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody bene fit from adjuvant fluorouracil-based chemotherapy? J Clin Oncol 25:4379-4386
13. Dahl O, Fluge O, Carlsen E et al (2009) Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncol 48:368-376
14. De Gramont A, Van Cutsem E, Tabernero J et al (2011) AVANT: results from a randomized three-arm multinational phase III study to investigate bevaci-zumab with either XELOX or FOLFOX4 versus FOLFOX alone as adjuvant treatment for colon cancer. J Clin Oncol 29(suppl 4):A 362
15. de Gramont A, Hubbard J, Shi Q et al (2010) Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20, 800 patient ACCENT data set. J Clin Oncol 28:460-465
16. Des Guetz G, Nicolas P, Perret GY et al (2010) Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 46:1049-1055
17. Dewdney A, Capdevila J, Glimelius B et al (2011) Expert-C: a randomized phase II European multicenter trial of neoadjuvant chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-de fined, high-risk rectal cancer. Proc Am Soc Clin Oncol; J Clin Oncol 29:suppl abstract 3513
18. Fernandez-Martos C, Pericay C, Aparicio J et al (2010) Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-de fined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 28:859-865
19. Fietkau R, Barten M, Klautke G et al (2006) Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemo-radiotherapy of rectal cancer. Dis Colon Rectum 49:1284-1292
20. Figueredo A, Coombes, ME, Mukherjee S (2008) Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev (3): CD005390
21. Folkesson J, Birgisson H, Påhlman L et al (2005) Swedish Rectal Cancer Trial: long lasting bene fits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644-5650
22. Fountzilas G, Zisiadis A, Dafni U et al (1999) Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 10:671-676
23. Fransen K, Klintenas M, Osterstrom A et al (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25:527-533
24. Gastrointestinal Tumor StudyGroup (1985)Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465-1472
25. Glimelius B (2010) Adjuvant chemotherapy in rectal cancer-an issue or a non-issue? Ann Oncol 21: 1739-1741
26. Glimelius B, Dahl O, Cedermark B et al (2005) Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 44:904-912
27. Gray R, McConkey C (2008) Adjuvant chemotherapy for rectal cancer: authors' reply. Lancet 371:1503
28. Hafstrom L, Rudenstam CM, Domellof L (1985) A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time. Br J Surg 72:138-141
29. Hafström L, Domellöf L, Rudenstam CM et al (1990) Adjuvant chemotherapy with 5-fluorouracil, vincris-tine and CCNU for patients with Dukes' C colorectal cancer. The Swedish Gastrointestinal Tumour Adjuvant Therapy Group. Br J Surg 77:1345-1348
30. Haller DG, Tabernero J, Maroun J et al (2011) Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29:1465-1471
31. Hamaguchi T, Shirao K, Moriya Y et al (2011) Final results of randomized trials by the national surgical adjuvant study of colorectal cancer (NSAS-CC). Cancer Chemother Pharmacol 67:587-596
32. Hojo K, Kajitani T (1986) Adjuvant chemotherapy of colorectal cancer-results of prospective randomized trials. Gan To Kagaku Ryoho 13:3063-3073
33. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252
34. Khrizman P, Niland JC, ter Veer A et al (2011) Postoperative adjuvant chemotherapy (CTX) use in patients (Pts) with stage II/III rectal cancer treated with neoadjuvant therapy: a National Comprehensive Cancer Network (NCCN) analysis. J Clin Oncol 29:suppl; abstr 3515
35. Kuebler JP, Wieand HS, O'Connell MJ et al (2007) Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 25:2198-2204
36. Kusters M, Valentini V, Calvo FA et al (2010) Results of European pooled analysis of IORT-containing mul-timodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 21:1279-1284
37. Mansour EG, Lefkopoulou M, Johnson R et al (1991) A comparison of postoperative adjuvant chemotherapy, radiotherapy or combination therapy in potentially curable resectable rectal carcinoma. An ECOG study Est 4276. Proc Am Soc Clin Oncol 10:154 abstr
38. McAllister SS, Weinberg RA (2010) Tumor-host interactions: a far-reaching relationship. J Clin Oncol 28:4022-4028
39. Minoo P, Zlobec I, Peterson M et al (2010) Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein pro files. Int J Oncol 37:707-718
40. National Comprehensive Cancer Network (2011) Rectal cancer. NCCN clinical practice guidelines in oncology Version 3
41. NCI (1991) Clinical announcement. Adjuvant therapy of rectal cancer. National Cancer Institute, Bethesda
42. Pahlman L, Bohe M, Cedermark B et al (2007) The Swedish rectal cancer registry. Br J Surg 94: 1285-1292
43. Quasar Collaborative Group, Gray R, Barnwell J et al (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370:2020-2029
44. Ragnhammar P, Brorsson B, Nygren P et al (2001) A prospective study of the use of chemotherapy in Sweden and assessment of the use in relation to scienti fic evidence. Acta Oncol 40:391-411
45. Sakamoto J, Hamada C, Kodaira S et al (1999) Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analy-sis of randomized trials. Jpn J Clin Oncol 29:78-86
46. Sakamoto J, Hamada C, Yoshida S et al (2007) An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with cura-tively resected rectal cancer. Br J Cancer 96:1170-1177
47. Slattery ML, Wolff E, Hoffman MD et al (2011) MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer 50:196-206
48. Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987
49. Taal BG, Van Tinteren H, Zoetmulder FA (2001) Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 85:1437-1443
50. Tiefenthal M, Nilsson PJ, Johansson R et al (2011) The effects of short-course preoperative irradiation on local recurrence rate and survival in rectal cancer: a population-based nationwide study. Dis Colon Rectum 54:672-680
51. Valentini V, Glimelius B (2010) Rectal cancer radiotherapy: towards European consensus. Acta Oncol 49:1206-1216
52. Valentini V, van Stiphout RG, Lammering G et al (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29:3163-3172
53. van de Velde CJH (2010) Chronicle/PROCTOR/SCRIPT trials. European Multidisciplinary Colorectal Cancer Congress, Nice, 28-30 Mar, 2010, Oral presentation